Division of Translational Surgical Oncology, National Center for Tumor Diseases (NCT/UCC) Dresden, Dresden, Germany.
Department of Visceral-, Thoracic and Vascular Surgery, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
Sci Rep. 2023 May 9;13(1):7506. doi: 10.1038/s41598-023-34168-x.
Clinically relevant postoperative pancreatic fistula (CR-POPF) can significantly affect the treatment course and outcome in pancreatic cancer patients. Preoperative prediction of CR-POPF can aid the surgical decision-making process and lead to better perioperative management of patients. In this retrospective study of 108 pancreatic head resection patients, we present risk models for the prediction of CR-POPF that use combinations of preoperative computed tomography (CT)-based radiomic features, mesh-based volumes of annotated intra- and peripancreatic structures and preoperative clinical data. The risk signatures were evaluated and analysed in detail by visualising feature expression maps and by comparing significant features to the established CR-POPF risk measures. Out of the risk models that were developed in this study, the combined radiomic and clinical signature performed best with an average area under receiver operating characteristic curve (AUC) of 0.86 and a balanced accuracy score of 0.76 on validation data. The following pre-operative features showed significant correlation with outcome in this signature ([Formula: see text]) - texture and morphology of the healthy pancreatic segment, intensity volume histogram-based feature of the pancreatic duct segment, morphology of the combined segment, and BMI. The predictions of this pre-operative signature showed strong correlation (Spearman correlation co-efficient, [Formula: see text]) with the intraoperative updated alternative fistula risk score (ua-FRS), which is the clinical gold standard for intraoperative CR-POPF risk stratification. These results indicate that the proposed combined radiomic and clinical signature developed solely based on preoperatively available clinical and routine imaging data can perform on par with the current state-of-the-art intraoperative models for CR-POPF risk stratification.
临床上相关的胰瘘(CR-POPF)可显著影响胰腺癌患者的治疗过程和结果。CR-POPF 的术前预测可以辅助手术决策过程,并有助于改善患者的围手术期管理。在这项对 108 例胰头切除术患者的回顾性研究中,我们提出了使用术前 CT (计算机断层扫描)基于放射组学特征、基于网格的标注胰内和胰周结构体积以及术前临床数据组合来预测 CR-POPF 的风险模型。通过可视化特征表达图和将显著特征与已建立的 CR-POPF 风险测量方法进行比较,详细评估和分析了风险特征。在所开发的风险模型中,综合放射组学和临床特征的表现最佳,验证数据的平均接收者操作特征曲线下面积(AUC)为 0.86,平衡准确性评分 0.76。在该特征中,以下术前特征与结果显著相关([公式:见文本])-健康胰段的纹理和形态、胰管段的强度体积直方图特征、组合段的形态和 BMI。该术前特征的预测与术中更新的替代瘘风险评分(ua-FRS)具有很强的相关性(Spearman 相关系数,[公式:见文本]),ua-FRS 是术中 CR-POPF 风险分层的临床金标准。这些结果表明,仅基于术前可用的临床和常规成像数据开发的综合放射组学和临床特征可与目前用于 CR-POPF 风险分层的最先进的术中模型相媲美。